Statements (108)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Umang_Vohra
|
| gptkbp:country |
gptkb:India
|
| gptkbp:focus |
antibiotics
cardiology immunology neurology oncology paediatrics women's health critical care dermatology gastroenterology nephrology ophthalmology pain management urology diabetes care HIV/AIDS treatment antiretroviral drugs anti-infectives vitamins and supplements anti-androgens allergy treatment anti-obesity drugs anti-alcoholism drugs anti-allergics anti-anxiety drugs anti-asthmatics anti-cancer drugs anti-coagulants anti-constipation drugs anti-dementia drugs anti-depressants anti-diabetics anti-diarrheals anti-emetics anti-epileptics anti-estrogens anti-fungals anti-gout drugs anti-histamines anti-hormonal drugs anti-hypercalcemics anti-hyperchloremics anti-hyperglycemics anti-hyperkalemics anti-hyperlipidemics anti-hypermagnesemics anti-hypernatremics anti-hyperphosphatemics anti-hypertensives anti-hyperuricemics anti-hypocalcemics anti-hypochloremics anti-hypoglycemics anti-hypokalemics anti-hypolipidemics anti-hypomagnesemics anti-hyponatremics anti-hypophosphatemics anti-hypouricemics anti-lipidemics anti-malarials anti-migraine drugs anti-osteoporotic drugs anti-parkinsonian drugs anti-platelets anti-progestins anti-psychotics anti-rheumatics anti-smoking drugs anti-spasmodics anti-thrombotics anti-thyroid drugs anti-tuberculosis drugs anti-ulcerants anti-virals respiratory medicines |
| gptkbp:foundedBy |
gptkb:Khwaja_Abdul_Hamied
|
| gptkbp:foundedYear |
1935
|
| gptkbp:headquartersLocation |
gptkb:Mumbai
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:ISIN |
INE059A01026
|
| gptkbp:keyPerson |
gptkb:Samina_Hamied
gptkb:Yusuf_Hamied |
| gptkbp:listedOn |
gptkb:SENSEX
gptkb:Nifty_50 |
| gptkbp:logo |
Cipla logo.svg
|
| gptkbp:market |
global
|
| gptkbp:notableFor |
affordable HIV/AIDS drugs
|
| gptkbp:numberOfEmployees |
over 25,000
|
| gptkbp:parentCompany |
gptkb:Cipla_Limited
|
| gptkbp:products |
over-the-counter drugs
active pharmaceutical ingredients generic medicines |
| gptkbp:revenue |
over $2 billion (2023)
|
| gptkbp:servesArea |
worldwide
|
| gptkbp:stockExchange |
gptkb:NSE
BSE |
| gptkbp:subsidiary |
gptkb:Cipla_Medpro
gptkb:Cipla_USA_Inc. |
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
https://www.cipla.com/
|
| gptkbp:bfsParent |
gptkb:erythropoietin
gptkb:Yusuf_Hamied |
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cipla
|